Please try another search
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer. Its lead product, DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors. The company was founded in 1996 and is headquartered in Bethesda, Maryland.
Name | Age | Since | Title |
---|---|---|---|
Linda F. Powers | 65 | 2007 | Chairperson, CEO, President, CFO & Chief Accounting Officer |
Alton L. Boynton | 76 | 1998 | Founder, Chief Scientific Officer, Secretary & Director |
J. Cofer Black | 74 | 2016 | Independent Director |
Jerome Galon | - | - | Member of Scientific Advisory Board |
Samir N. Khleif | 60 | - | Member of Scientific Advisory Board |
Martin Cheever | 80 | - | Member of the Scientific Advisory Board |
John F. Smyth | - | - | Member of Scientific Advisory Board |
Henry Brem | 71 | 2005 | Member of Clinical Advisory Board |
Darell D. Bigner | - | 2005 | Member of Clinical Advisory Board |
Steven S. Brem | - | 2005 | Member of Clinical Advisory Board |
Tom Mikkelsen | - | 2005 | Member of Clinical Advisory Board |
Linda M. Liau | 56 | 2005 | Member of Scientific Advisory Board |
Navid Malik | 55 | 2012 | Independent Director |
Pat Sarma | 79 | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review